Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Sandoz Inc

« Back to Dashboard

Sandoz Inc Drugs with Tentative Approvals

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Sandoz Inc	bimatoprost	203056	0.01%	SOLUTION; OPHTHALMIC
Sandoz Inc	pregabalin	091229	50MG	CAPSULE; ORAL
Sandoz Inc	mesalamine	202065	1000MG	SUPPOSITORY;RECTAL
Sandoz Inc	lisdexamfetamine dimesylate	202836	50MG	CAPSULE;ORAL
Sandoz Inc	pregabalin	091229	100MG	CAPSULE; ORAL
Sandoz Inc	fesoterodine fumarate	204844	4MG	TABLET, EXTENDED RELEASE;ORAL
Sandoz Inc	lisdexamfetamine dimesylate	202836	30MG	CAPSULE;ORAL
Applicant	Generic Name	NDA	Strength	Dosage Form

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.